Bristol Myers Squibb has denied claims it is making a further 10% reduction to its work force, and said any new reported cuts are still part of the same cost saving plan it announced a year ago.
Several articles - triggered by a Reuters report - said BMS was to expand its plan to downsize and cut its global workforce by an extra 10% before 2010, on top of the first 10% cut it announced in December 2007.
But BMS said it has long planned all redundancies ahead in order to reduce costs and offset patent expiries on drugs, and allegations it was making fresh cuts were false.
More at Pharmafocus
No comments:
Post a Comment